Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin (Q28379448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

chemotherapy

0 references

peripheral neuropathy

1 reference

1 reference

1 reference

Martin J van den Bent

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

P H Hilkens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L C Pronk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Verweij

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C J Vecht

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

W L van Putten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

417-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

31 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Peripheral neurotoxicity induced by docetaxel.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Sequences of taxol and cisplatin: a phase I and pharmacologic study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Peripheral neuropathy secondary to docetaxel (Taxotere)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063386

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials Group

27 November 2018

1 reference

12 December 2020

Paclitaxel (Taxol) induces cumulative mild neurotoxicity

1 reference

12 December 2020

Taxol produces a predominantly sensory neuropathy

1 reference

12 December 2020

Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity

1 reference

12 December 2020

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

12 December 2020

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

1 reference

12 December 2020

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

1 reference

12 December 2020

The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro

1 reference

12 December 2020

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 October 2019

1002958514

0 references

Fatcat ID

release_bryphqjuvzg45ngtcxa2q5mpoa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bryphqjuvzg45ngtcxa2q5mpoa

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9020489%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference